Long term survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Cells, Cultured Cell Line, Tumor Cell Line Neurons Tumor Cells, Cultured Brain Lung Liver Kidney T-Lymphocytes Lymph Nodes

Organisms7

Mice, Inbred C57BL Mice, Knockout Mice, Inbred BALB C Mice, Transgenic Rats, Sprague-Dawley Animals, Newborn Mice, Nude

Diseases40

Postoperative Complications Recurrence Neoplasm Recurrence, Local Lung Neoplasms Breast Neoplasms Disease Progression Adenocarcinoma Neoplasm Metastasis Brain Neoplasms Neoplasms Liver Neoplasms Disease Models, Animal Lymphatic Metastasis Carcinoma, Squamous Cell Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Chronic Disease Pancreatic Neoplasms Neoplasm Invasiveness Long QT Syndrome Melanoma Carcinoma, Hepatocellular Acute Disease Stomach Neoplasms Ovarian Neoplasms Carcinoma Glioblastoma Kidney Failure, Chronic Bone Neoplasms Prostatic Neoplasms Myocardial Infarction Kidney Neoplasms Esophageal Neoplasms Body Weight Glioma Heart Arrest Multiple Myeloma Skin Neoplasms Colonic Neoplasms Head and Neck Neoplasms

Chemicals and Drugs36

Antineoplastic Agents Tumor Markers, Biological RNA, Messenger Cisplatin Cyclophosphamide Doxorubicin Fluorouracil Immunosuppressive Agents Antibodies, Monoclonal Survival of Motor Neuron 1 Protein Proto-Oncogene Proteins Vincristine Prednisone Recombinant Proteins Phosphatidylinositol 3-Kinases Neoplasm Proteins Methotrexate Biological Markers Transcription Factors DNA-Binding Proteins Tumor Suppressor Protein p53 Protein-Serine-Threonine Kinases Deoxycytidine Enzyme Inhibitors Etoposide RNA, Small Interfering Membrane Proteins Nerve Growth Factors DNA Paclitaxel Antimetabolites, Antineoplastic Antibodies, Monoclonal, Humanized Receptor, erbB-2 Survival of Motor Neuron 2 Protein bcl-X Protein Cytokines

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Survival Rate Prognosis Survival Analysis Follow-Up Studies Retrospective Studies Treatment Outcome Prospective Studies Kaplan-Meier Estimate Neoplasm Staging Disease-Free Survival Proportional Hazards Models Long-Term Care Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Risk Factors Cohort Studies Multivariate Analysis Immunohistochemistry Drug Administration Schedule Predictive Value of Tests Risk Assessment Models, Biological Disease Models, Animal Analysis of Variance Registries Chemotherapy, Adjuvant Transplantation, Homologous Randomized Controlled Trials as Topic Reoperation Reverse Transcriptase Polymerase Chain Reaction Incidence Liver Transplantation Kidney Transplantation Severity of Illness Index Clinical Trials as Topic Actuarial Analysis Blotting, Western Regression Analysis Remission Induction Gene Expression Profiling Life Tables Radiotherapy, Adjuvant Cause of Death Heart Transplantation Statistics, Nonparametric Drug Therapy, Combination Chi-Square Distribution Longitudinal Studies Probability Treatment Failure Case-Control Studies Transfection Palliative Care Random Allocation SEER Program Polymerase Chain Reaction Patient Selection Renal Dialysis Body Weight Radiotherapy Double-Blind Method Radiotherapy Dosage Oligonucleotide Array Sequence Analysis Neoadjuvant Therapy Cell Count Transplantation, Autologous Questionnaires Logistic Models Postoperative Period Models, Statistical Risk Epidemiologic Methods Bone Marrow Transplantation Mortality Administration, Oral Hepatectomy Sensitivity and Specificity Cardiopulmonary Resuscitation Biopsy Salvage Therapy Tomography, X-Ray Computed

Phenomena and Processes45

Time Factors Cell Survival Graft Survival Apoptosis Signal Transduction Term Birth Mutation Cell Proliferation Pregnancy Dose-Response Relationship, Drug Base Sequence Graft Rejection Gene Expression Regulation, Neoplastic Cell Differentiation Phenotype Phosphorylation Amino Acid Sequence Cell Death Microbial Viability Gene Expression Regulation Gene Expression Chi-Square Distribution Cell Division Tissue Survival Probability Longevity Transfection Kinetics Up-Regulation Algorithms Body Weight Genotype Time Enzyme Activation Transcription, Genetic Gestational Age Cell Count Down-Regulation Drug Resistance, Neoplasm Protein Binding Aging Risk Cell Movement Temperature Sensitivity and Specificity

Disciplines and Occupations2

Immunohistochemistry Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science12

Survival Rate Molecular Sequence Data Registries Base Sequence Incidence Amino Acid Sequence Life Tables Cause of Death SEER Program Algorithms Questionnaires Mortality

Named Groups4

Infant, Newborn Survivors Tissue Donors Infant, Premature

Health Care49

Survival Rate Survival Analysis Follow-Up Studies Retrospective Studies Treatment Outcome Prospective Studies Age Factors Kaplan-Meier Estimate Disease-Free Survival Proportional Hazards Models Long-Term Care Risk Factors Cohort Studies Multivariate Analysis Predictive Value of Tests Risk Assessment Analysis of Variance Registries Randomized Controlled Trials as Topic Incidence Severity of Illness Index Clinical Trials as Topic Actuarial Analysis Regression Analysis Sex Factors Life Tables Cause of Death Statistics, Nonparametric Chi-Square Distribution Longitudinal Studies Probability Treatment Failure Case-Control Studies Palliative Care Random Allocation SEER Program Patient Selection Double-Blind Method Cost-Benefit Analysis Outcome Assessment (Health Care)Questionnaires Logistic Models Postoperative Period Models, Statistical Risk Epidemiologic Methods Mortality Temperature Sensitivity and Specificity

Geographicals6

United States England Great Britain Europe Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Survival Rate Prognosis Survival Analysis Follow-Up Studies Retrospective Studies Time Factors Treatment Outcome Postoperative Complications Prospective Studies Age Factors Cell Survival Kaplan-Meier Estimate Neoplasm Staging Disease-Free Survival Survival Graft Survival Proportional Hazards Models Long-Term Care Apoptosis Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Risk Factors Cohort Studies Recurrence Multivariate Analysis Signal Transduction Neoplasm Recurrence, Local Lung Neoplasms Term Birth Breast Neoplasms Immunohistochemistry Antineoplastic Agents Cells, Cultured Mice, Inbred C57BL Disease Progression Cell Line, Tumor Infant, Newborn Tumor Markers, Biological Adenocarcinoma Molecular Sequence Data Drug Administration Schedule Mutation Cell Proliferation Neoplasm Metastasis Predictive Value of Tests Brain Neoplasms Pregnancy Neoplasms Risk Assessment Liver Neoplasms Models, Biological Disease Models, Animal Analysis of Variance Registries RNA, Messenger Chemotherapy, Adjuvant Cell Line Dose-Response Relationship, Drug Base Sequence Transplantation, Homologous Lymphatic Metastasis Cisplatin Graft Rejection Mice, Knockout Cyclophosphamide Carcinoma, Squamous Cell Doxorubicin Fluorouracil Colorectal Neoplasms Randomized Controlled Trials as Topic Reoperation Reverse Transcriptase Polymerase Chain Reaction Incidence Gene Expression Regulation, Neoplastic Liver Transplantation Quality of Life Kidney Transplantation Carcinoma, Non-Small-Cell Lung Severity of Illness Index Mice, Inbred BALB C Clinical Trials as Topic Actuarial Analysis Chronic Disease Blotting, Western Regression Analysis Cell Differentiation Remission Induction United States Neurons Mice, Transgenic Gene Expression Profiling Phenotype Survivors Immunosuppressive Agents Antibodies, Monoclonal Pancreatic Neoplasms Phosphorylation Sex Factors Amino Acid Sequence Survival of Motor Neuron 1 Protein

No FAQ available that match "long term survival"